SCHEMBL9447121

SCHEMBL9447121

CCOc1ccccc1CN1C=NCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.51
KDM4E B2RXH2 3/20 0.46
TP53 P04637 2/20 0.46
POLB P06746 1/20 0.46
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
HTR1A P08908 1/20 0.44
DRD2 P14416 1/20 0.44
HTR2B P41595 1/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 3/20 0.43
THRB P10828 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 2/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
ATM Q13315 1/20 0.43
PLEC Q15149 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203518 0.92 MAPT (0.44) MAPTKDM4ETP53POLBALOX15
SCHEMBL9447022 0.89 HTR1A (0.46) MAPTKDM4ETP53POLBHTR1A
SCHEMBL9447113 0.87 L3MBTL1 (0.45) MAPTKDM4ETP53POLBHTT
SCHEMBL9207834 0.80 KCNH2 (0.44) MAPTKDM4EALOX15HTTL3MBTL1
SCHEMBL9447066 0.77 ADRA2B (0.38) HTR1AMEN1KMT2AGAA
SCHEMBL4629576 0.72 TAAR1 (0.40) HTR1ADRD2KMT2A
SCHEMBL1143420 0.72 MAPT (0.68) MAPTKDM4ETP53POLBALOX15
SCHEMBL3717493 0.70 ALDH1A1 (0.50) MAPTKDM4ETP53HTR1AHTR2B
SCHEMBL11033419 0.70 MAPT (0.65) MAPTKDM4ETP53POLBALOX15
SCHEMBL3278648 0.69 HTR7 (0.43) DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250286-A Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline AEGIS TECHNOLOGY, INC. (US) 1993-10-05 US disclosed
EP-0527925-A4 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY INHALATION OF AN IMIDAZOLINE 1993-09-15 EP disclosed
EP-0527925-A1 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY INHALATION OF AN IMIDAZOLINE AEGIS TECHNOLOGIE, INC. (US) 1993-02-24 EP disclosed
US-5096916-A Administering tolazoline AEGIS TECHNOLOGY, INC. (US) 1992-03-17 US disclosed
WO-1991016891-A1 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY INHALATION OF AN IMIDAZOLINE AEGIS TECHNOLOGY, INC. (US) 1991-11-14 WO disclosed